Latest News on Coronavirus vaccination in india
Showing of 0 - 10 from 8 results
Coronavirus vaccination in india - Total results - 8

Apr 08, 2021
India reports 1,26,789 new COVID-19 cases, highest single-day spike since pandemic
Registering a steady increase for the 29th day in row, the count of active cases has gone up to 9,10,319, which is 7.04% of the total count
Jan 25, 2021
Over 19.5L COVID-19 vaccinations, 348 AEFIs so far; Delhi heading to 'herd immunity', suggests sero-survey
India recorded the lowest number of coronavirus fatalities in over eight months, with 131 deaths being reported on Monday, the health ministry said
Jan 21, 2021
Over 10 lakh healthcare workers immunised against COVID-19, says Centre; 187 AEFIs reported today
Meanwhile, five people died in a fire that broke out in a facility of the Serum Institute of India (SII) in Pune's Manjari area. SII is manufacturing the Oxford-AstraZeneca vaccine, 'Covishield'
Jan 18, 2021
COVID-19 vaccination: 3.81 lakh inoculated, 580 suffer adverse events; Delhi sees dip in turnout
Monday, which was the third day of the inoculation drive in the country, also saw a record dip in the number of COVID-19 deaths
Jan 04, 2021
Covaxin trials conducted with '200% honesty', says Bharat Biotech MD; new COVID-19 cases under 20,000 for 3rd day
The global efforts to curb the spread of COVID-19 got a boost in the UK, as it became the first country to administer a vaccine against the virus
Sep 20, 2020
India surpasses US in global COVID-19 recoveries as tally exceeds 53 lakh; SII to begin phase III trials from Monday
Apart from the Oxford candidate, two more vaccine candidates in India are in advanced stages of clinical trials, while four are in pre-clinical development stage
Aug 21, 2020
Coronavirus vaccine may hit Indian market by first quarter of 2021, says health minister Harsh Vardhan
Two homegrown vaccine candidates — Covaxin by Bharat Biotech and ZyCOV-D by Zydus Cadila — have almost finished the phase II clinical trials
Jul 08, 2020
COVID-19 vaccine in India: Government to set guidance document for trials of vaccines, treatment
No process in vaccine development trials will be skipped, but approvals to carry out multiple phases of trials parallelly may be given.



 (1).jpg)





